These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3995166

  • 1. Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement.
    De Fabritiis P, Bregni M, Lipton J, Greenberger J, Nadler L, Rothstein L, Korbling M, Ritz J, Bast RC.
    Blood; 1985 May; 65(5):1064-70. PubMed ID: 3995166
    [Abstract] [Full Text] [Related]

  • 2. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
    Bast RC, De Fabritiis P, Lipton J, Gelber R, Maver C, Nadler L, Sallan S, Ritz J.
    Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224
    [Abstract] [Full Text] [Related]

  • 3. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC.
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [Abstract] [Full Text] [Related]

  • 4. Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complement.
    De Fabritiis P, Bregni M, Lipton J, Reynolds C, Nadler L, Ritz J, Bast RC.
    Leuk Res; 1986 Mar; 10(1):35-42. PubMed ID: 2935682
    [Abstract] [Full Text] [Related]

  • 5. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres.
    O'Briant KC, Shpall EJ, Houston LL, Peters WP, Bast RC.
    Cancer; 1991 Sep 15; 68(6):1272-8. PubMed ID: 1873781
    [Abstract] [Full Text] [Related]

  • 6. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
    Uckun FM, Kersey JH, Haake R, Weisdorf D, Ramsay NK.
    Blood; 1992 Feb 15; 79(4):1094-104. PubMed ID: 1531306
    [Abstract] [Full Text] [Related]

  • 7. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
    Lemoli RM, Gasparetto C, Scheinberg DA, Moore MA, Clarkson BD, Gulati SC.
    Blood; 1991 Apr 15; 77(8):1829-36. PubMed ID: 2015406
    [Abstract] [Full Text] [Related]

  • 8. Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement.
    Haleem A, Kurtzberg J, Olsen GA, Rhinehardt-Clark A, Leslie DS, Ray L, Smith CA, Peters WP, Haynes BF, Bast RC.
    Cancer Res; 1987 Sep 01; 47(17):4608-12. PubMed ID: 3113721
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells.
    Roy DC, Griffin JD, Belvin M, Blättler WA, Lambert JM, Ritz J.
    Blood; 1991 Jun 01; 77(11):2404-12. PubMed ID: 2039821
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
    Stahel RA, Mabry M, Sabbath K, Speak JA, Bernal SD.
    Int J Cancer; 1985 May 15; 35(5):587-92. PubMed ID: 2987136
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of a cocktail of monoclonal antibodies and human complement in selective killing of acute lymphocytic leukemia cells.
    Sugita K, Majdic O, Stockinger H, Holter W, Köller U, Peschel C, Knapp W.
    Int J Cancer; 1986 Mar 15; 37(3):351-7. PubMed ID: 3456339
    [Abstract] [Full Text] [Related]

  • 20. Regrowth of granulocyte-macrophage progenitor cells (GM-CFC) in suspension cultures of bone marrow depleted of GM-CFC with 4-hydroperoxycyclophosphamide (4-HC).
    Beran M, Zander AR, Andersson BS, McCredie KB.
    Eur J Haematol; 1987 Aug 15; 39(2):118-24. PubMed ID: 3666100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.